招銀國際:料偉能集團(1608.HK)可如期釋放盈利增長 重申“買入”評級
招銀國際發表研究報告指出,受東南亞區域強勁的電力需求增長支持,偉能集團(1608.HK)將釋放其增長動能,並將如期在2020/21財年釋放盈利增長,重申予偉能集團“買入”的評級,維持目標價3.25港元,對應2020/21年預測市盈率為20.2/12.8倍。
報告指,偉能集團最近與中國技術進出口組成合營企業,共同在緬甸開發三個產能共計900MW的IBO發電項目;亦在斯里蘭卡簽署了兩個新的發電項目,在這個新開發的國家市場獲得了近100MW項目規模。新型肺炎爆發,但偉能集團僅受輕微的影響。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.